MACRILEN (macimorelin) for oral solution. Initial U.S. Approval: 2017

MACRILEN (macimorelin) for oral solution. Initial U.S. Approval: 2017

INDICATIONS AND USAGE
MACRILEN is a growth hormone (GH) secretagogue receptor agonist indicated for the diagnosis of adult growth hormone deficiency.
DOSAGE FORMS & STRENGTHS
For oral solution: 60 mg
Manufactured By: Aeterna Zentaris GmbH
Prescribing Information URL: Click Here

Access to MACRILEN (macimorelin) for oral solution: Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Macimorelin (INN), or Macrilen (trade name) is a drug being developed by Æterna Zentaris for use in the diagnosis of adult growth hormone deficiency. Macimorelin acetate, the salt formulation, is a synthetic growth hormone secretagogue receptor agonist.The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.